Many people with COPD can control their symptoms by using inhaled medicines each day. But inhaled medicines may not offer enough relief for people who also have high levels of a type of white ...
Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, discusses insights from the FLAME trial analysis and the ICS-RECODE meta-analysis.
With COPD, you have lung damage that worsens over time. Trelegy Ellipta does not come as a generic drug. Trelegy Ellipta comes in a dry powder inhaler. Each active ingredient in Trelegy Ellipta ...
Triple therapy inhalers for COPD can reduce exacerbations but may increase pneumonia risk, necessitating careful patient phenotype assessment. Roflumilast and azithromycin effectively reduce COPD ...
Patients with COPD often experience chronic cough, difficulty breathing, and reduced lung function. While the respiratory disease is not curable, it can be treated and managed with medications ...
While people with asthma or chronic obstructive pulmonary disease (COPD) can experience worse symptoms due to climate change, many of the medications they’re prescribed also contribute to ...